Clinical Management and Guidance Working Group

Date: Friday 18 October 2019
Time: 16:00 – 18:00
Chair: Toni Seppälä (Finland), Andy Latchford (UK)

Time Session
16:00 – 16:20 Survival by colon cancer stage and screening interval in Lynch Syndrome: a Prospective Lynch Syndrome Database report – Mev Dominguez-Valetin (Norway)
16:20 – 16:40 Revision of the ‘Mallorca Group’ Guidelines for PJS – Anja Wagner (Germany)
16:40 – 16:55 BRAF mutation testing of MSI CRCs in Lynch syndrome diagnostics: performance and efficiency according to patient’s age – Aysel Ahadova (Germany)
16:55 – 17:10 Assessment of family history and genetic testing among young persons with colorectal cancer – Erik Lundqvist (Sweden)
17:10 – 17:25 Application and timing of MMR ICH in Tumours of patients with advanced cancer – Terri McVeigh (UK)
17:25: 17:55 EHTG Guidance for LS: where are we and where are we going when? – Toni Seppälä (Finland), Andy Latchford (UK)
17:55 – 18:00 Closing remarks
Top